Cargando…

Saam Acupuncture for Treating Functional Dyspepsia: A Feasibility Randomized Controlled Trial

OBJECTIVE: Functional dyspepsia (FD) is a common gastrointestinal disorder that significantly affects sufferers' quality of life and increases the economic burden on society. Saam acupuncture, a form of traditional Korean acupuncture, is frequently used to treat FD in Korean medicine clinical s...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Boram, Kwon, O.-Jin, Kim, Joo-Hee, Kang, Jung Won, Kim, Tae-Hun, Lee, Seunghoon, Kim, Jungeun, Kim, Ae-Ran, Jung, So Young, Park, Hyo-Ju, Choi, Sun-Mi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259230/
https://www.ncbi.nlm.nih.gov/pubmed/35815291
http://dx.doi.org/10.1155/2022/2581041
_version_ 1784741729217282048
author Lee, Boram
Kwon, O.-Jin
Kim, Joo-Hee
Kang, Jung Won
Kim, Tae-Hun
Lee, Seunghoon
Kim, Jungeun
Kim, Ae-Ran
Jung, So Young
Park, Hyo-Ju
Choi, Sun-Mi
author_facet Lee, Boram
Kwon, O.-Jin
Kim, Joo-Hee
Kang, Jung Won
Kim, Tae-Hun
Lee, Seunghoon
Kim, Jungeun
Kim, Ae-Ran
Jung, So Young
Park, Hyo-Ju
Choi, Sun-Mi
author_sort Lee, Boram
collection PubMed
description OBJECTIVE: Functional dyspepsia (FD) is a common gastrointestinal disorder that significantly affects sufferers' quality of life and increases the economic burden on society. Saam acupuncture, a form of traditional Korean acupuncture, is frequently used to treat FD in Korean medicine clinical settings. This study aimed to evaluate the feasibility and preliminary effectiveness and safety of Saam acupuncture for treating FD. METHODS: We conducted a pilot, pragmatic, assessor-blinded randomized controlled trial. Patients with FD according to the ROME III criteria were randomly allocated to an acupuncture plus usual care group or a usual care group. Saam acupuncture based on individualized FD and systemic symptoms was conducted in the acupuncture group three times per week for 4 weeks. Study feasibility outcomes, including recruitment, completion, and acupuncture adherence rates, were calculated. In addition, preliminary evaluation of participant responses to the intervention was tested using the gastrointestinal symptom (GIS), FD-related quality of life (FD-QoL), visual analog scale (VAS), patient global assessment (PGA), and EuroQol-5 Dimensions (EQ-5D) scores. RESULTS: Twenty-four participants who met the eligibility criteria were included. The recruitment and completion rates of the clinical trials were 60% and 79.2%, and the acupuncture adherence rate was 83.3%. Although there was no significant difference between the two groups in the dyspepsia symptoms as measured by GIS, VAS, and PGA at Week 4, significant differences were found between the two groups at the follow-up assessments (Weeks 8 and 12). In particular, the early satiety subscore of GIS was significantly improved in the Saam acupuncture group compared with the usual care group at Week 4. The quality of life measured by FD-QoL and EQ-5D improved only in the Saam acupuncture group, although there were no significant differences between the two groups. No adverse events related to Saam acupuncture were reported. CONCLUSIONS: Saam acupuncture can be a feasible, preliminarily effective, and safe treatment for FD. Further confirmatory trials with a larger sample size are needed to confirm its effectiveness and safety. The trail is registered with CRIS-KCT0000164, URL: https://cris.nih.go.kr/cris/search/detailSearch.do/2098.
format Online
Article
Text
id pubmed-9259230
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-92592302022-07-07 Saam Acupuncture for Treating Functional Dyspepsia: A Feasibility Randomized Controlled Trial Lee, Boram Kwon, O.-Jin Kim, Joo-Hee Kang, Jung Won Kim, Tae-Hun Lee, Seunghoon Kim, Jungeun Kim, Ae-Ran Jung, So Young Park, Hyo-Ju Choi, Sun-Mi Evid Based Complement Alternat Med Research Article OBJECTIVE: Functional dyspepsia (FD) is a common gastrointestinal disorder that significantly affects sufferers' quality of life and increases the economic burden on society. Saam acupuncture, a form of traditional Korean acupuncture, is frequently used to treat FD in Korean medicine clinical settings. This study aimed to evaluate the feasibility and preliminary effectiveness and safety of Saam acupuncture for treating FD. METHODS: We conducted a pilot, pragmatic, assessor-blinded randomized controlled trial. Patients with FD according to the ROME III criteria were randomly allocated to an acupuncture plus usual care group or a usual care group. Saam acupuncture based on individualized FD and systemic symptoms was conducted in the acupuncture group three times per week for 4 weeks. Study feasibility outcomes, including recruitment, completion, and acupuncture adherence rates, were calculated. In addition, preliminary evaluation of participant responses to the intervention was tested using the gastrointestinal symptom (GIS), FD-related quality of life (FD-QoL), visual analog scale (VAS), patient global assessment (PGA), and EuroQol-5 Dimensions (EQ-5D) scores. RESULTS: Twenty-four participants who met the eligibility criteria were included. The recruitment and completion rates of the clinical trials were 60% and 79.2%, and the acupuncture adherence rate was 83.3%. Although there was no significant difference between the two groups in the dyspepsia symptoms as measured by GIS, VAS, and PGA at Week 4, significant differences were found between the two groups at the follow-up assessments (Weeks 8 and 12). In particular, the early satiety subscore of GIS was significantly improved in the Saam acupuncture group compared with the usual care group at Week 4. The quality of life measured by FD-QoL and EQ-5D improved only in the Saam acupuncture group, although there were no significant differences between the two groups. No adverse events related to Saam acupuncture were reported. CONCLUSIONS: Saam acupuncture can be a feasible, preliminarily effective, and safe treatment for FD. Further confirmatory trials with a larger sample size are needed to confirm its effectiveness and safety. The trail is registered with CRIS-KCT0000164, URL: https://cris.nih.go.kr/cris/search/detailSearch.do/2098. Hindawi 2022-06-29 /pmc/articles/PMC9259230/ /pubmed/35815291 http://dx.doi.org/10.1155/2022/2581041 Text en Copyright © 2022 Boram Lee et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Lee, Boram
Kwon, O.-Jin
Kim, Joo-Hee
Kang, Jung Won
Kim, Tae-Hun
Lee, Seunghoon
Kim, Jungeun
Kim, Ae-Ran
Jung, So Young
Park, Hyo-Ju
Choi, Sun-Mi
Saam Acupuncture for Treating Functional Dyspepsia: A Feasibility Randomized Controlled Trial
title Saam Acupuncture for Treating Functional Dyspepsia: A Feasibility Randomized Controlled Trial
title_full Saam Acupuncture for Treating Functional Dyspepsia: A Feasibility Randomized Controlled Trial
title_fullStr Saam Acupuncture for Treating Functional Dyspepsia: A Feasibility Randomized Controlled Trial
title_full_unstemmed Saam Acupuncture for Treating Functional Dyspepsia: A Feasibility Randomized Controlled Trial
title_short Saam Acupuncture for Treating Functional Dyspepsia: A Feasibility Randomized Controlled Trial
title_sort saam acupuncture for treating functional dyspepsia: a feasibility randomized controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259230/
https://www.ncbi.nlm.nih.gov/pubmed/35815291
http://dx.doi.org/10.1155/2022/2581041
work_keys_str_mv AT leeboram saamacupuncturefortreatingfunctionaldyspepsiaafeasibilityrandomizedcontrolledtrial
AT kwonojin saamacupuncturefortreatingfunctionaldyspepsiaafeasibilityrandomizedcontrolledtrial
AT kimjoohee saamacupuncturefortreatingfunctionaldyspepsiaafeasibilityrandomizedcontrolledtrial
AT kangjungwon saamacupuncturefortreatingfunctionaldyspepsiaafeasibilityrandomizedcontrolledtrial
AT kimtaehun saamacupuncturefortreatingfunctionaldyspepsiaafeasibilityrandomizedcontrolledtrial
AT leeseunghoon saamacupuncturefortreatingfunctionaldyspepsiaafeasibilityrandomizedcontrolledtrial
AT kimjungeun saamacupuncturefortreatingfunctionaldyspepsiaafeasibilityrandomizedcontrolledtrial
AT kimaeran saamacupuncturefortreatingfunctionaldyspepsiaafeasibilityrandomizedcontrolledtrial
AT jungsoyoung saamacupuncturefortreatingfunctionaldyspepsiaafeasibilityrandomizedcontrolledtrial
AT parkhyoju saamacupuncturefortreatingfunctionaldyspepsiaafeasibilityrandomizedcontrolledtrial
AT choisunmi saamacupuncturefortreatingfunctionaldyspepsiaafeasibilityrandomizedcontrolledtrial